Evaluation of Macitentan in Patients With Eisenmenger Syndrome. [electronic resource]
Producer: 20191022Description: 51-63 p. digitalISSN:- 1524-4539
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antihypertensive Agents -- adverse effects
- Biomarkers -- blood
- Child
- Double-Blind Method
- Down Syndrome -- complications
- Eisenmenger Complex -- complications
- Endothelin Receptor Antagonists -- adverse effects
- Exercise Tolerance -- drug effects
- Female
- Hemodynamics -- drug effects
- Humans
- Hypertension, Pulmonary -- diagnostic imaging
- Male
- Middle Aged
- Natriuretic Peptide, Brain -- blood
- Peptide Fragments -- blood
- Pulmonary Artery -- drug effects
- Pyrimidines -- adverse effects
- Recovery of Function
- Sulfonamides -- adverse effects
- Time Factors
- Treatment Outcome
- Walk Test
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.